doi: 10.1371/journal.pone.0042357
As is reflective of the wider under-recognition of women in science, women's contributions to the development of GLP-1 drugs have taken time to be fully appreciated (Barany, Barany)
An open-label extension trial to evaluate the long-term safety of apraglutide in short bowel syndrome
Conversely, transplanting the microbiome from a healthy twin drives weight loss
This cleavage rapidly inactivates the incretins, limiting their effectiveness in promoting intestinal homeostasis ( Emerging hypothesis and therapeutic rationale Translational studies have sought to map the protective properties of GLP-1 and GLP-2 to clinical applications for patients with IBD
Rosenstock J, Wysham C, Frias JP, Kaneko S, Lee CJ, Fernandez Lando L, et al